Document is current

This article is maintained by: Elsevier

Article Title: Aggressive Inferior Eyelid Basal Cell Carcinoma: Advantage of Neoadjuvant Vismodegib

Journal Title: Actas Dermo-Sifiliográficas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.adengl.2018.05.039

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2018.05.022

Content Type: article

Copyright: © 2019 Elsevier España, S.L.U. and AEDV. Published by Elsevier España, S.L.U.